An automated, normative-based fluorodeoxyglucose positron emission tomography image-analysis procedure to aid Alzheimer disease diagnosis using statistical parametric mapping and interactive image display

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6144 III, Issue , 2006, Pages

  Chen, Kewei ^a,b,c,e,i   Ge, Xiaolin ^d   Yao, Li ^e   Bandy, Dan ^a,i   Alexander, Gene E ^b,i   Prouty, Anita ^a,i   Burns, Christine ^a,i   Zhao, Xiaojie ^e   Wen, Xiaotong ^e   Korn, Ronald ^f   Lawson, Michael ^f   Reiman, Eric M ^a,g,h,i  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d Mata Systems   (United States)

^e BEIJING NORMAL UNIVERSITY   (China)

^f Scottsdale Medical Imaging   (United States)

^g UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^h TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

ⁱ ARIZONA ALZHEIMER S CONSORTIUM   (United States)

Author keywords

Alzheimer disease (AD); Clinical computing system; Clinical diagnosis; Computer aided diagnosis; Fluorodeoxyglucose (FDG); Normal database; Positron Emission Tomography (PET); Statistical general linear model; Voxel based image analysis

Indexed keywords

ALZHEIMER DISEASE (AD); CLINICAL COMPUTING SYSTEM; CLINICAL DIAGNOSIS; FLUORODEOXYGLUCOSE (FDG); NORMAL DATABASE; STATISTICAL GENERAL LINEAR MODEL; VOXEL-BASED IMAGE-ANALYSIS;

DATABASE SYSTEMS; DECISION MAKING; DISEASES; IMAGE ANALYSIS; MEDICAL IMAGING; PATIENT TREATMENT;

POSITRON EMISSION TOMOGRAPHY;

EID: 33745127024     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.651069     Document Type: Conference Paper

References (15)

1. Silverman, D., Small, S., Chang, C., Lu, C. & et al. Positron Emission Tomography in Evaluation of Dementia Regional Brain Metabolism and Long-term Outcome. JAMA 286, 2120-2127 (2001).
2. Small, G. W. et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A 97, 6037-6042 (2000).
3. Alexander, G. E., Chen, K., Pietrini, P., Rapoport, S. I. & Reiman, E. M. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Am. J. Psychiatry 159, 738-745 (2002).
4. Reiman, E. M. et al. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A 98, 3334-3339 (2001).
5. Reiman, E. M. et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334, 752-758 (1996).
6. Reiman, E. M. et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad Sci. U. S. A 101, 284-289 (2004).
7. Reiman, E. M. et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl. Acad. Sci. U. S. A 102, 8299-8302 (2005).
8. Reiman, E. M. et al. Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography. Neuroreport 11, 987-991 (2000).
9. Reiman EM, Caselli RJ, Yun, L. S., Chen K & Bandy, D. Evidence of Alzheimer's disease in cognitively normal persons heterozygous for the 14 allele of apolipoprotein E using positron emission tomography. 1998. Ref Type: Conference Proceeding
10. Reiman, E. et al. Effects of apolipoprotien E e4 gene dose and brain atrophy on baseline PET measurements of erebral glucose metabolism. 9th International Conference of Alzheimer's Disease and Related Disorders (2004).
11. Chen, K. et al. Non-invasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluorodexyglucose, the Patlak method, and an image-derived input function. J Cereb. Blood Flow Metab 716-723 (1998).
12. Talairach, J. & Tournoux, P. Co-planar stereotaxic atlas of the human brain: Three-dimensional proportional system. Stuttgart, Germany, Georg Thieme, (1988).
13. Friston, K. J. et al. Spatial registration and normalisation of images. Human Brain Mapping 2, 165-189 (1995).
14. Ashburner, J. & Friston, K. J. Nonlinear spatial normalization using basis functions. Hum. Brain Mapp. 1, 254-266 (1999).
15. Tzourio-Mazoyer, N. et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 15, 273-289 (2002).